Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsclinical-pharmacology-and-therapeutics

Paeds SAQs · clinical-pharmacology-and-therapeutics

Complementary, alternative and traditional medicines — formative SAQs

Two formative SAQs on complementary, alternative and traditional medicines in children: the five CAM domains and why most use is undisclosed, the four pathways to harm (heavy-metal contamination, herb-drug interactions, misidentification and dosing inconsistency, delay of conventional care), the bedside safety conversation, and the regional regulatory and evidence picture.

20 marks30 min5 min readVerification in progress

Target exams

RACP General PaediatricsRACP DWEMRCPCH TheoryMRCPCH ClinicalABP General Pediatrics
On this page
Study tools

Target exams

RACP General PaediatricsRACP DWEMRCPCH TheoryMRCPCH ClinicalABP General Pediatrics
Prompt
Complementary, alternative and traditional medicines in children

SAQ 1 — Classification, prevalence and the bedside safety conversation

Stem (20 marks; suggested 15 minutes): [1]

A four-year-old child of South Asian heritage presents with three weeks of abdominal pain, constipation and lethargy. The blood count shows a microcytic anaemia. On direct, non-judgemental questioning, the mother reveals the child has been taking an Ayurvedic preparation "for strength" for two months. Separately, the mother of a 10-year-old with epilepsy asks whether the St John's wort she has started giving him "for mood" is safe alongside his antiseizure medicines. [8] [5]

(a) Define complementary and alternative medicine (CAM), name the five CAM domains, and classify the two products above into the most relevant domain. (8 marks) [1]

(b) Outline the stepwise bedside safety conversation you would have with each family, and state why routine, non-judgemental asking is the single most important intervention. (8 marks) [4]

(c) For the first child, state the most likely diagnosis, the first-line investigation, and one immediate management step. (4 marks) [6]

Model answer — SAQ 1

(a) Definition, five domains and classification (8 marks). [1]

  • Definition — CAM is a diverse group of health systems, practices and products not presently considered part of conventional biomedicine: complementary when used alongside conventional care, alternative when used instead of it, integrative when evidence-based CAM is combined with conventional care in a coordinated way. (2 marks)
  • Five domains — (1) biologically based therapies (herbs, botanicals, vitamins, supplements); (2) mind-body medicine (meditation, yoga, hypnosis); (3) manipulative and body-based practices (massage, chiropractic, osteopathy); (4) energy therapies (Reiki, biofield); (5) whole medical systems (Ayurveda, traditional Chinese medicine, homeopathy, naturopathy, Indigenous healing). (5 marks)
  • Classification — the Ayurvedic preparation is a whole medical system product (Ayurveda) and is the principal source of heavy-metal contamination; the St John's wort is a biologically based therapy (botanical) and is the principal source of herb-drug interactions. (1 mark) [1] [7]

(b) Bedside safety conversation (8 marks — the six steps, 1 mark each, capped at 8). [4]

  1. Ask respectfully and routinely — use open, normalised wording ("Lots of families give their children herbs, vitamins or traditional remedies — does your child take any?") rather than closed or judgemental questions. [4]
  2. Document every remedy — name, dose, frequency, route, source and recommender, in the same place as conventional medicines. [4]
  3. Screen for interactions and contamination — for the St John's wort, check against the antiseizure medicines for CYP3A4 interactions; for the Ayurvedic preparation, consider heavy-metal contamination. [5]
  4. Assess the evidence and the risk — is it directly harmful; is it substituting for proven care; is the child particularly vulnerable? [4]
  5. Counsel honestly and collaboratively — explain the assessment in plain language, respect the family's beliefs, use shared decision-making; do not dismiss CAM wholesale. [4]
  6. Coordinate and follow up — integrate agreed safe CAM, arrange follow-up, report adverse events. [4]

Routine, non-judgemental asking is the single most important intervention because non-disclosure is the default — a parent who fears disapproval will not volunteer CAM use, so the only way to surface the hidden pathways is to ask openly and routinely. (credit within step 1) [1]

(c) Diagnosis, investigation and immediate management (4 marks). [6]

  • Most likely diagnosis — lead poisoning from a contaminated Ayurvedic preparation; the abdominal pain, constipation, lethargy and microcytic anaemia are the classic paediatric presentation. (1 mark) [8]
  • First-line investigation — a venous blood lead level (with arsenic and mercury levels if the exposure history suggests them); basophilic stippling on the blood film supports the diagnosis. (2 marks) [6]
  • Immediate management step — stop the Ayurvedic product and involve the toxicology service (chelation is guided by the blood level and specialist advice; supportive care is the backbone). Arrange for the product to be tested and notify public health. (1 mark) [8]

SAQ 2 — Herb-drug interactions, homeopathy and the regulatory picture

Stem (20 marks; suggested 15 minutes): [5]

A fellowship examiner asks: "Why does complementary and alternative medicine sometimes harm children, and how should clinicians and regulators respond?" [1] [4]

(a) Describe the four pathways by which CAM use harms children, giving a named example of each. (10 marks) [7]

(b) Summarise the evidence on homeopathic products for children, and describe the regulatory frameworks in the WHO, UK, Australia and the United States. (10 marks) [10]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References7ShowHide
  1. [1]Ernst E Prevalence of complementary/alternative medicine for children: a systematic review. Eur J Pediatr, 1999.PMID 9950300
  2. [4]Gilmour J, Harrison C, Asadi L et al. Informed consent: advising patients and parents about complementary and alternative medicine therapies. Pediatrics, 2011.PMID 22045862
  3. [5]Feucht C, Patel DR Herbal medicines in pediatric neuropsychiatry. Pediatr Clin North Am, 2011.PMID 21281847
  4. [6]McRae A, Vilcins D, Le HHTC et al. Lead in traditional and complementary medicine: a systematic review. Rev Environ Health, 2024.PMID 36322973
  5. [7]Ernst E Heavy metals in traditional Indian remedies. Eur J Clin Pharmacol, 2002.PMID 11936709
  6. [8]Datta-Mitra A, Ahmed O Jr Ayurvedic medicine use and lead poisoning in a child: a continued concern in the United States. Clin Pediatr (Phila), 2015.PMID 25305259
  7. [10]Hawke K, King D, van Driel ML et al. Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children. Cochrane Database Syst Rev, 2022.PMID 36511520
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousChemotherapy and supportive pharmacology — formative SAQsclinical-pharmacology-and-therapeuticsNextCorticosteroid therapy and adverse effects — formative SAQsclinical-pharmacology-and-therapeutics